Table 5. Remission at Treatment Exit with MDMA-assisted psychotherapy.

* at long term follow-up, at around 12 months, the remission rate increased from 56% to 67% (n=72)

MDMA: 3,4-methylenedioxymethamphetamine

MP-16: NCT03282123 [22]; MP-17: NCT03485287 [23]

Citation	No longer meeting PTSD Criteria (N, %)
Buoso et al, 2008 [18]	4, 67%
Jerome et al, 2020 [29]	60, 56%*
MP-16 [22]	24, 75%
MP-17 [23]	4, 100%